{
  "ptid_time": "022_S_0544_2006-05-17",
  "img_path": "/data/qiuhui/data/adni/images/022_S_0544/2006-05-17/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 54,911 mm³, 95.6% above the reference mean. With a Z-score of 2.19 (98.6th percentile), this represents significant enlargement; hippocampal volume measures 4,445 mm³, 37.5% below the reference mean. With a Z-score of -3.44 (0.0th percentile), this represents profound atrophy; whole brain volume measures 877,538 mm³, 10.0% below the reference mean. With a Z-score of -1.25 (10.5th percentile), this represents mild atrophy; entorhinal cortex volume measures 2,475 mm³, 32.6% below the reference mean. With a Z-score of -2.00 (2.3th percentile), this represents significant atrophy; fusiform gyrus volume measures 13,254 mm³, 22.1% below the reference mean. With a Z-score of -2.01 (2.2th percentile), this represents significant atrophy; middle temporal gyrus volume measures 16,440 mm³, 14.2% below the reference mean. With a Z-score of -1.24 (10.8th percentile), this represents mild atrophy. ",
  "text_data": "Age is 76.7 years. Gender is Female. Education: 12 years. Handedness: Right. Race: White. Medical history: Psychiatric; Neurologic; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Respiratory; Musculoskeletal; Gastrointestinal; Hematopoietic-Lymphatic; Renal-Genitourinary; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 28.0. Logical Memory: 4.0. APOEε4 alleles: 0.0. Biomarker levels: Amyloid beta: 461.60 pg/mL (mild reduced); Total tau: 150.20 pg/mL (mild reduced); Phosphorylated tau: 12.46 pg/mL (mild reduced). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant hippocampal and entorhinal cortex atrophy, both hallmark features of Alzheimer's disease, alongside ventricular enlargement and mild-to-moderate atrophy in other temporal lobe regions. Despite the MMSE being normal (28/30), the structural changes are highly suggestive of neurodegeneration, and the mild reductions in Aβ and tau biomarkers may indicate early pathological changes.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer’s pathology)  \n**Confidence:** **Medium** (due to normal MMSE but strong structural evidence of atrophy)",
  "timestamp": "2025-07-26T02:05:43.612638"
}